IndraLab

Statements

BRCC3 inhibits CRBN. 1 / 1

| 1

reach

"Lys-63-specific deubiquitinase BRCC36 enhances the sensitivity of multiple myeloma cells to lenalidomide by inhibiting lysosomal degradation of cereblon."

39136771

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

BRCC3 inhibits CRBN. 1 / 1

INDRA sources:

Databases

Reading